# studies | Pooled treatment CFR, % (95% CI) | τ2 | |
Overall | 211 | 5.16 (4.20 to 6.34) | 1.961 |
Adult | 73 | 4.62 (3.17 to 6.75) | 2.155 |
Paediatric | 27 | 6.50 (2.65 to 10.36) | 3.463 |
HIV− | 52 | 3.33 (2.00 to 5.52) | 2.640 |
HIV+ | 35 | 10.91 (7.68 to 15.50) | 0.900 |
Drug sensitive | 104 | 3.58 (2.59 to 4.97) | 2.389 |
Drug resistant | 43 | 14.06 (10.15 to 19.49) | 0.921 |
Public sector | 193 | 5.40 (4.39 to 6.64) | 1.811 |
Private sector | 14 | Not pooled | 4.058 |
Primary/secondary centre | 91 | 5.18 (4.07 to 6.60) | 1.247 |
Tertiary centre | 116 | 4.87 (3.42 to 6.94) | 2.936 |
Private sector was not pooled due to high heterogeneity.
CFR, case fatality ratio.